Invest now
MedPlus Health Services share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹660.60(0.31%)September 11, 2026 15:29:52 PM IST
- NSE
- BSE
- Vol : 81.75 K (NSE + BSE)Last 20 day avg : 266.38 K
MedPlus Health Services is trading 0.31% upper at Rs 660.60 as compared to its last closing price. MedPlus Health Services has been trading in the price range of 661.95 & 653.05. MedPlus Health Services has given -18.49% in this year & -0.39% in the last 5 days. MedPlus Health Services has TTM P/E ratio 46.19 as compared to the sector P/E of 22.38.There are 6 analysts who have initiated coverage on MedPlus Health Services. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 33.18 Crores in its last quarter.Listed peers of MedPlus Health Services include Novelix Pharmaceuticals (3.32%), Muller & Phipps India Ltd (4.21%).The Mutual Fund holding in MedPlus Health Services was at 24.51% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in MedPlus Health Services was at 14.38% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 13 Sep 2026, 01:52 PM IST
- BetaLow volatility0.43Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.72The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values4.00The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values37.56Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.59The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
MedPlus Health Services News
MedPlus Health Services Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Novelix Pharmaceuticals | 77.50 | 3.32 | 220.64 | 52.28 | 2.87 | - | 9.30 |
| Muller & Phipps India Ltd | 217.80 | 4.21 | 13.61 | - | - | - |
Mutual Fund Ownership
View allMedPlus Health Services Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-21 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-05-20 | Audited Results |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
About the company MedPlus Health Services
- IndustryRetail (Drugs)
- ISININE804L01022
- BSE Code543427
- NSE CodeMEDPLUS
MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through three segments: Retail, Diagnostics, and Others. The Retail segment is engaged in trading pharmaceuticals and general items through its retail stores and online platform. The Diagnostics segment includes diagnostic services, pathological services, and laboratory testing services. The other segment includes the insurance broking business. Its products include Pharmaceutical and wellness products and Fast-moving consumer goods (FMCG). Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its e-commerce portals include MedPlus Mart, MedPlus Lens, and MedPlus Labs.
MedPlus Health Services Share Price FAQs
MedPlus Health Services is trading at 660.60 as on Fri Sep 11 2026 09:59:52. This is 0.31% upper as compared to its previous closing price of 658.55.
The market capitalization of MedPlus Health Services is 7886.56 Cr as on Fri Sep 11 2026 09:59:52.
The average broker rating on MedPlus Health Services is Strong Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for MedPlus Health Services is 1020.35 whereas the 52 wk low is 647.25
MedPlus Health Services can be analyzed on the following key metrics -
- TTM P/E: 46.19
- Sector P/E: 22.38
- Dividend Yield: 0.00%
- D/E ratio: -
MedPlus Health Services reported a net profit of 219.65 Cr in 2026.
The Mutual Fund Shareholding was 24.51% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
MedPlus Health Services QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.